CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Protalix Biotherapeutics Inc Company Snapshot
Protalix Biotherapeutics Inc operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Protalix Biotherapeutics Inc with three other companies in this sector in the United States: Novavax, Inc. (2018 sales of $34.29 million of which 100% was Pharmaceutical Products), Editas Medicine Inc ($31.94 million of which 100% was Pharmaceutical), and Agenus Incorporation ($36.78 million of which 100% was Pharmacl preparations).

Sales Analysis. During the year ended December of 2018, sales at Protalix Biotherapeutics Inc were $34.24 million. This is an increase of 77.9% versus 2017, when the company's sales were $19.24 million. This was the third consecutive year of growth at Protalix Biotherapeutics Inc.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Protalix Biotherapeutics Inc
  Stock Performance Chart for Protalix Biotherapeutics Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (9/13/2019): .23
(Figures in U.S. Dollars)
1 Week 3.4%   13 Weeks -1.5%  
4 Weeks -46.3%   52 Weeks -55.0%  
 
Protalix Biotherapeutics Inc Key Data:
  Ticker: PLX Country: Israel
  Exchanges: ASE Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2018 Sales 34,240,000
(Year Ending Jan 2019).
Employees: 184
  Currency: U.S. Dollars Market Cap: 33,756,973
  Fiscal Yr Ends: December Shares Outstanding: 148,382,299
  Share Type: Common Closely Held Shares: 9,238,719
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.